Jupiter Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-480,540
Closed -$20.8M 460
2025
Q1
$20.8M Buy
+480,540
New +$24.3M 0.2% 156
2024
Q2
Sell
-407,417
Closed -$28.1M 414
2024
Q1
$28.1M Buy
407,417
+62,078
+18% +$3.93M 0.27% 128
2023
Q4
$25.5M Buy
345,339
+163,117
+90% +$10.7M 0.25% 127
2023
Q3
$12.4M Buy
+182,222
New +$15.5M 0.14% 179
2023
Q2
Sell
-13,282
Closed -$901K 525
2023
Q1
$901K Sell
13,282
-12,920
-49% -$830K 0.01% 347
2022
Q4
$1.3M Buy
26,202
+5,435
+26% +$222K 0.02% 355
2022
Q3
$675K Hold
20,767
0.01% 415
2022
Q2
$818K Buy
+20,767
New +$1.11M 0.01% 452

Other funds holding EXAS

Jupiter Asset Management's EXAS Position: Q2 2025 in Review

Jupiter Asset Management sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 480,540 shares — an estimated $20.8M sold.

Jupiter Asset Management first reported a position in EXAS in Q2 2022 and held it in 8 quarters. The position peaked at $28.1M in Q1 2024. 558 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • Jupiter Asset Management reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
  • Jupiter Asset Management sold 480,540 Exact Sciences shares in Q2 2025, an estimated $20.8M.
  • Jupiter Asset Management first reported a position in Exact Sciences in Q2 2022 and held it in 8 quarters.
  • Jupiter Asset Management's Exact Sciences position peaked at $28.1M in Q1 2024.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on Jupiter Asset Management's 13F filing for Q2 2025, filed 8 Aug 2025.